Can Augmentin Be Taken with Maintenance Azithromycin in COPD?
Yes, Augmentin (amoxicillin-clavulanate) can be safely taken alongside maintenance azithromycin in COPD patients, and you do not need to stop the prophylactic azithromycin during an acute exacerbation requiring Augmentin.
Key Guideline Recommendation
The British Thoracic Society explicitly states: "It is not necessary to stop prophylactic azithromycin during an acute exacerbation of COPD unless another antibiotic with potential to affect the QT interval has also been prescribed" 1. Since Augmentin does not prolong the QT interval, this combination is safe from a cardiac standpoint.
Safety Considerations
QT Interval Monitoring
- Azithromycin is a macrolide that can prolong the QT interval, which is why baseline and 1-month follow-up ECGs are required when initiating maintenance therapy 1
- Augmentin does not affect the QT interval 2
- The critical concern with azithromycin is avoiding co-administration with other QT-prolonging antibiotics (such as fluoroquinolones or certain other macrolides), not with beta-lactams like Augmentin
Drug Interaction Profile
The FDA label for azithromycin notes that when co-administered with other antibiotics, careful monitoring is warranted, but there are no specific contraindications to concurrent use with amoxicillin-clavulanate 3. The Augmentin label similarly does not list macrolides as problematic co-medications 2.
Clinical Evidence
Research directly comparing these agents shows they can be used in similar patient populations without safety concerns:
- A study comparing azithromycin versus amoxicillin-clavulanate for COPD exacerbations found both were effective and safe, with no mention of contraindications to sequential or concurrent use 4
- Large-scale cardiovascular safety data comparing macrolides to amoxicillin in COPD patients found no increased risk of major adverse cardiovascular events 5
Practical Management Algorithm
When a COPD patient on maintenance azithromycin develops an acute exacerbation:
Continue the maintenance azithromycin at its usual dose (typically 250-500 mg three times weekly) 1, 6
Add Augmentin for the acute exacerbation as clinically indicated
Monitor for:
Do NOT obtain a new ECG specifically for this combination unless the patient develops new cardiac symptoms
Important Caveats
When to Exercise Caution
- If the patient is on other QT-prolonging medications (antiarrhythmics, certain antipsychotics, fluoroquinolones), reassess the overall regimen 1
- If baseline QTc was borderline (approaching but not exceeding 450 ms in men or 470 ms in women), consider clinical monitoring
- Elderly patients or those with multiple comorbidities may have increased gastrointestinal side effects from dual antibiotic therapy
Antibiotic Resistance Considerations
The Canadian Thoracic Society guidelines recommend adding maintenance macrolides only after triple inhaler therapy (LAMA/LABA/ICS) has failed to prevent exacerbations 6. When treating acute exacerbations in patients already on azithromycin, the choice of additional antibiotic should consider:
- Local resistance patterns
- Previous sputum culture results
- Severity of the current exacerbation
Research shows that amoxicillin alone (without clavulanate) may be equally effective for COPD exacerbations and is associated with lower rates of pneumonia hospitalization 7, though this doesn't preclude using Augmentin when clinically appropriate.
Bottom Line
The combination is safe and does not require stopping maintenance azithromycin. The primary monitoring concern is additive gastrointestinal side effects, not drug-drug interactions or cardiac toxicity. Continue both medications and complete the Augmentin course as prescribed for the acute exacerbation.